Skip to content

Stydy of Papaya extract verses Povidine iodine in dressing of surgical wound and outcomes

Comparative study of safty and effectivness of Papaya dressing with Povidone-Iodine Preparation(10%) in surgical site infected wound at Tertiary care hospital - NIL

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/057035
Enrollment
138
Registered
2023-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L768- Other intraoperative and postprocedural complications of skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Rajiv Sonarkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: diagnosed cases of surgical site infection

Exclusion criteria

Exclusion criteria: 1)Patient suffering from severe systemic illness (severe anaemia, diabetes, hypothyroidism) 2)Patient suffering from immune deficiency ( HIV infection, steroid therapy) 3)Patient of complete burst abdomen 4)Patient with allergy to any of the study medication

Design outcomes

Primary

MeasureTime frame
What is the safety and effectiveness of papaya dressing in treatment of surgical site infected wound in tertiary care hospital? Timepoint: 2 weeks

Secondary

MeasureTime frame
What are the outcomes of papaya dressing in treatment of surgical site infected wound in tertiary care hospital?Timepoint: 2 weeks

Countries

India

Contacts

Public ContactDr.Rajiv Sonarkar

Datta Meghe Medical Collage

drsrajiv@rediffmail.com09422142779

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026